2/29/2024  9:03:09 AM Chg. +2.25 Volume Bid9:08:07 AM Ask9:08:07 AM Market Capitalization Dividend Y. P/E Ratio
1,052.50GBX +0.21% 9,839
Turnover(GBP): 103,176.9025
1,047.00Bid Size: 180 1,049.00Ask Size: 308 9.12 bill.GBP - -

Business description

Smith & Nephew plc is a global medical technology business. The company has two reportable business segments: Advanced Surgical Devices (Orthopaedic Reconstruction, Trauma & Extremities, Sports Medicine and Arthroscopy Enabling Technologies) and Advanced Wound Management. Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. The company has distribution channels, purchasing agents and buying entities in over 100 countries worldwide. Smith & Nephew plc is headquartered in London, UK.
 

Management board & Supervisory board

CEO
Deepak Nath
Management board
Anne-Françoise Nesmes, Brad Cannon, Paul Connolly, Phil Cowdy, Myra Eskes, Mizanu Kebede, Elga Lohler, Vasant Padmanabhan, Alison Parkes, Helen Barraclough, Scott Schaffner
Supervisory board
Roberto Quarta, Rupert Soames, Deepak Nath, Anne-Françoise Nesmes, Marc Owen, Jo Hallas, John Ma, Angie Risley, Bob White, Katarzyna Mazur-Hofsaess, Rick Medlock
 

Company data

Name: Smith & Nephew plc
Address: Building 5, Croxley Park Hatters Lane Watford,Hertfordshire WD18 8YE UK
Phone: +44-1923-477-100
Fax: -
E-mail: -
Internet: www.smith-nephew.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: -
IPO date: -

Investor relations

Name: Andrew Swift
IR phone: +44-117-378-5450
IR Fax: -
IR e-mail: Investorrelations.gl...hew.com Investorrelations.global@smith-nephew.com

Main Shareholders

Others
 
94.80%
BlackRock, Inc
 
5.20%